The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
Enabling a new era in minimally invasive obesity treatment across Europe
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Poviztra is a second brand of Wegovy
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Subscribe To Our Newsletter & Stay Updated
